Management of diabetic ketoacidosis

Indian Journal of Pediatrics

Volumn 78, Issue 5, 2011, Pages 576-584

  Sivanandan, Sindhu ^a   Sinha, Aditi ^a   Jain, Vandana ^a   Lodha, Rakesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cerebral edema; Hyperglycemia; Insulin therapy; Ketosis; Pediatric

Indexed keywords

BICARBONATE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN LISPRO; MANNITOL; PHOSPHATE; POTASSIUM;

BLOOD GLUCOSE MONITORING; BRAIN EDEMA; CHILD; CHILD HEALTH CARE; CLINICAL CHEMISTRY; CLINICAL FEATURE; CONFERENCE PAPER; DEHYDRATION; DIABETIC KETOACIDOSIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ELECTROLYTE DISTURBANCE; FLUID THERAPY; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN TREATMENT; INTESTINE NECROSIS; KETONURIA; KIDNEY FAILURE; LOW DRUG DOSE; LUNG EDEMA; METABOLIC ACIDOSIS; MUCORMYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCLUSIVE CEREBROVASCULAR DISEASE; PANCREATITIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSICAL EXAMINATION; PREVALENCE; RECOMMENDED DRUG DOSE; RHABDOMYOLYSIS; RISK FACTOR; TREATMENT DURATION; VEIN THROMBOSIS;

BICARBONATES; BRAIN EDEMA; CHILD; DIABETIC KETOACIDOSIS; FLUID THERAPY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PHOSPHATES; POTASSIUM; RISK FACTORS;

EID: 79958292549     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-010-0294-8     Document Type: Conference Paper

References (61)

1. Edge J, Ford-Adams M, Dunger D. Causes of death in children with insulin-dependent diabetes 1990-96. Arch Dis Child. 1999;81:318-23.
2. Dunger DB, Sperling MA, Acerini CL, et al. European Society for Pediatric Endocrinology/Lawson Wilkins pediatric endocrine society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004;113:e133-40.
3. Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents. A consensus statement from the American Diabetes Association. Diab Care. 2006;29:1150-9.
4. Sherry NA, Levitsky LL. Management of diabetic ketoacidosis in children and adolescents. Pediatr Drugs. 2008;10:209-15.
5. Jenkins D, Close C, Krentz A, et al. Euglycemic diabetic ketoacidosis: does it exist? Acta Diabetol. 1993;30:251-3.
6. Pinkey JH, Bingley PI, Sawtell PA, Dunger DB, Gale EA. Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford study group. Diabetologia. 1994;37:70-4.
7. Canarie MF, Bogue CW, Banasiak KJ, Weinzimer SA, Tamborlane WV. Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population. J Pediatr Endocrinol Metab. 2007;20:1115-24.
8. Levy-Marchal C, Patterson C, Green A. Geographical variation of presentation at diagnosis of type 1 diabetes in children: the EURODIAB study. Diabetologia. 2001;44:B75-80.
9. Rodacki M, Pereira JR, Nabuco De Oliveira AM, et al. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diab Res Clin Pract. 2007;78:259-62.
10. American Diabetes Association. Type 2 diabetes in children and adolescents. Diab Care. 2000;23:381-9.
11. Quinn M, Fleischman A, Rosner B, Nigrin DJ, Wolfsdorf JI. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr. 2006;148:366-71.
12. Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287:2511-8.
13. Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diab. 2009;10:33-7.
14. Agus MSD, Wolfsdorf JI. Diabetic ketoacidosis in children. Pediatr Clin N Am. 2005;52:1147-63.
15. Halperin M, Bear R, Goldstein M, et al. Interpretation of the serum potassium concentration in metabolic acidosis. Clin Invest Med. 1979;2:55-7.
16. Katz MA. Hyperglycemia-induced hyponatremia: calculation of expected serum sodium depression. N Engl J Med. 1973;289:843-4.
17. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia [see comment]. Am J Med. 1999;106:399-403.
18. Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diab. 2009;10:118-33.
19. Klein M, Sathasivam A, Novoa Y, Rapaport R. Recent consensus statements in pediatric endocrinology: a selective review. Endocrinol Metab Clin N Am. 2009;38:811-25.
20. Koves I, Neutze J, Donath S, et al. The accuracy of clinical assessment of dehydration during diabetic ketoacidosis in childhood. Diab Care. 2004;27:2485-7.
21. Smith L, Rotta A. Accuracy of clinical estimates of dehydration in pediatric patients with diabetic ketoacidosis. Pediatr Emerg Care. 2002;18:395-6.
22. Hanas R, Donaghue K, Klingensmith G, editors of the ISPAD, et al. Clinical practice consensus guidelines 2006-2007. Pediatr Diab. 2006;7:341-2.
23. Halperin M, Goldstein M, Richardson R, et al. Quantitative aspects of hyperglycemia in the diabetic: a theoretical approach. Clin Invest Med. 1980;2:127-30.
24. Linares MY, Schunk JE, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy. Pediatr Emerg Care. 1996;12:347-51.
25. Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diab. 2009;10:118-33.
26. Fleckman AM. Diabetic ketoacidosis. Endocrinol Metab Clin North Am. 1993;22:181-207.
27. Hoffman W, Burek C, Waller J, et al. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003;108:175-81.
28. Orlowski JP, Cramer CL, Fiallos MR. Diabetic ketoacidosis in the pediatric ICU. Pediatr Clin N Am. 2008;55:577-87.
29. Kitabchi AE, Umpierrez GE, Murphy MB, on behalf of the American Diabetes Association, et al. Hyperglycémie crises in diabetes. Diab Care. 2004;27:S94-S102.
30. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis: the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344:264-9.
31. Edge J, Jakes R, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49:2002-9.
32. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117:291-6.
33. Della Manna T, Steinmetz L, Campos Pr, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diab Care. 2005;28:1856-61.
34. Butkiewicz EK, Leibson CL, O'Brien PC, et al. Insulin therapy for diabetic ketoacidosis: bolus insulin injection versus continuous insulin infusion. Diab Care. 1995;18:1187-90.
35. Lindsay R, Bolte RG. The use of an insulin bolus in low-dose insulin infusion for pediatric diabetic ketoacidosis. Pediatr Emerg Care. 1989;5:77-9.
36. Kitabchi AE. Low-dose insulin therapy in diabetic ketoacidosis: fact or fiction? Diab Metab Rev. 1989;5:337-63.
37. Burghen G, Etteldorf J, Fisher J, et al. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diab Care. 1980;3:15-20.
38. Miles J, Gerich J. Glucose and ketone body kinetics in diabetic ketoacidosis. Clin Endocrinol Metab. 1983;12:303-19.
39. Kappy MS, Lightner ES. Low-dose intravenous insulin in the treatment of diabetic ketoacidosis. Am J Dis Child. 1979;133:523-5.
40. Glaser N. Pediatric diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Clin N Am. 2005;52:1611-35.
41. Grimberg A, Cerri R, Satin-Smith M, et al. The "two bag system" for variable intravenous dextrose and fluid administration: benefits in diabetic ketoacidosis management. J Pediatr. 1999;134:376-8.
42. Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diab. 2007;8:150-6.
43. Foster D, McGarry J. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983;309:159-69.
44. Tattersall RB. A paper which changed clinical practice (slowly). Jacob Holler on potassium deficiency in diabetic acidosis (1946). Diabet Med. 1999;16:978-84.
45. Malone JI, Brodsky SJ. The value of electrocardiogram monitoring in diabetic ketoacidosis. Diab Care. 1980;3:543-7.
46. Becker DJ, Brown DR, Steranka BH, et al. Phosphate replacement during treatment of diabetic ketosis: effects on calcium and phosphorus homeostasis. Am J Dis Child. 1983;137:241-6.
47. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983;57:177-80.
48. Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977;137:203-20.
49. Zipf WB, Bacon GE, Spencer ML, Kelch RP, Hopwood NJ, Hawker CD. Hypocalcemia, hypomagnesemia, and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diab Care. 1979;2:265-8.
50. Green S, Rothrock S, Ho J, et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998;31:41-8.
51. Okuda Y, Adrogue H, Field J, et al. Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab. 1996;81:314-20.
52. Bureau M, Begin R, Berthiaume Y, et al. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980;96:968-73.
53. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med. 2001;344:264-9.
54. Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med. 1987;106:615-8.
55. Flood RG, Chiang VW. Rate and prediction of infection in children with diabetic ketoacidosis. Am J Emerg Med. 2001;19:270-3.
56. 2 monitoring in pediatric in patients with diabetic ketoacidosis. Diabetes. 2004;53:A67.
57. Harris G, Fiordalisi I, Harris W, et al. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study. J Pediatr. 1990;117:22-31.
58. Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146:688-92.
59. Edge JA. Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause? Diab Metab Res Rev. 2000;16:316-24.
60. Marcin J, Glaser N, Barnett P, et al. Clinical and therapeutic factors associated with adverse outcomes in children with DKA-related cerebral edema. J Pediatr. 2003;141:793-7.
61. Dünger DB, Sperling MA, Aeerini CL, et al. European Society for Pediatric Endocrinology/Lawson Wilkins Pédiatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004;113:el33-140.